meprobamate has been researched along with Hepatic Insufficiency in 1 studies
Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)
Hepatic Insufficiency: Conditions in which the LIVER functions fall below the normal ranges. Severe hepatic insufficiency may cause LIVER FAILURE or DEATH. Treatment may include LIVER TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SCARPONI, E | 1 |
| NORBIATO, L | 1 |
1 other study available for meprobamate and Hepatic Insufficiency
| Article | Year |
|---|---|
[Psychosomatic aspects of hepatic insufficiency; therapeutic possibilities of drugs with central action (meprobamate, benactyzine, chlorpromazine) and with central and peripheral action (glucose-1-phosphate)].
Topics: Benactyzine; Chlorpromazine; Glucosephosphates; Hepatic Insufficiency; Hexosephosphates; Humans; Liv | 1958 |